BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Sealant, Dural

    PMA: P080013 · Supplement: S011 · Decision May 11, 2015
    View on FDA
    Classifications
    1
    FEI Numbers
    13
    Registration Numbers
    13

    Basic Information

    Device Name
    Sealant, Dural
    Trade Name
    DURASEAL EXACT SPINE SEALANT
    PMA Number
    P080013
    Supplement Number
    S011
    Device Class
    FDA Class 3
    Product Code
    NQR
    Generic Name
    Sealant, dural
    Medical Specialty
    Unknown
    Advisory Committee
    Neurology
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    May 11, 2015
    Date Received
    February 2, 2015
    Supplement Type
    Normal 180 Day Track No User Fee
    Supplement Reason
    Postapproval Study Protocol - OSB
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL OF THE FOLLOWING CHANGES TO THE POST-APPROVAL STUDY FOR THE DEVICE:1) CHANGE THE DEFINITION OF THE MINIMUM NECESSARY FOLLOW-UP FROM 60 TO 45 DAYS FOR THE RETROSPECTIVE CONTROL SUBJECTS ONLY; AND 2) ALLOW ANY NEW STUDY SITES THAT DO NOT HAVE 90 DAY STANDARD OF CARE VISITS TO ENROLL PROSPECTIVE SUBJECTS ONLY (DURASEAL AND/OR CONTROL). THIS WOULD ALLOW NEW SITES TO CONTRIBUTE SUBJECTS PROSPECTIVELY INSIDE THE STUDY WINDOW (60 TO 120 DAYS), BUT EXCLUDE RETROSPECTIVE SUBJECTS THAT WOULD POTENTIALLY HAVE BEEN SEEN OUTSIDE OF THE STUDY WINDOW THUS MAINTAINING CONTROL OVER FOLLOW-UP COMPLIANCE.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    NQR Sealant, Dural